When is it appropriate to use steroid eye drops for conjunctivitis, and what is the recommended dosing regimen?

Steroid Eye Drops for Conjunctivitis: When and How to Use

Steroid eye drops should be reserved for severe adenoviral conjunctivitis with marked chemosis, eyelid swelling, epithelial sloughing, or membranous conjunctivitis, and for symptomatic corneal subepithelial infiltrates causing vision impairment—but must be strictly avoided in herpes simplex virus (HSV) conjunctivitis where they potentiate epithelial infections. 1

Critical Decision Points: When to Use Steroids

AVOID Steroids in These Situations:

• HSV conjunctivitis: Topical corticosteroids potentiate HSV epithelial infections and are contraindicated 1
• Mild viral conjunctivitis without complications
• Uncomplicated bacterial conjunctivitis
• Early-stage adenoviral infection without severe features

USE Steroids in These Specific Scenarios:

1. Severe Adenoviral Keratoconjunctivitis

Use when patients present with:

• Marked chemosis (severe conjunctival swelling)
• Significant eyelid swelling
• Epithelial sloughing
• Membranous conjunctivitis 1

Rationale: Steroids reduce symptoms and may prevent scarring in severe cases, though animal models suggest prolonged viral shedding (human data unclear) 1

2. Symptomatic Corneal Subepithelial Infiltrates

These develop ≥1 week after adenoviral conjunctivitis onset. Use steroids when infiltrates cause:

• Blurred vision
• Photophobia
• Decreased visual acuity 1

For mild infiltrates without visual symptoms: Observation only 1

Recommended Steroid Regimen

Choice of Agent:

Prioritize safer corticosteroids with poor ocular penetration to minimize IOP elevation and cataract risk:

• Loteprednol (site-specific corticosteroid)
• Fluorometholone 1

These are preferred over dexamethasone or prednisolone acetate for conjunctivitis management.

Dosing Strategy:

• Start at minimum effective dose
• Taper slowly once inflammation is controlled 1
• Avoid abrupt discontinuation
• Treatment duration typically ≤2 weeks for acute conjunctivitis 2

Alternative for Subepithelial Infiltrates:

Cyclosporine drops (0.05% commercial or 0.1-1% compounded) can reduce infiltrates and may be used as steroid-sparing alternative 1

Mandatory Monitoring Protocol

For ALL patients on topical steroids:

• Regular follow-up visits (frequency based on severity)
• Each visit must include:
  • Interval history
  • Visual acuity measurement
  • Intraocular pressure (IOP) measurement (monitor for steroid-induced glaucoma)
  • Slit-lamp biomicroscopy
  • Pupillary dilation to evaluate for cataract formation 1

For severe disease with corneal ulceration or membranes: Re-evaluate within 1 week 1

Common Pitfalls to Avoid

1. Using steroids empirically without confirming etiology: Always rule out HSV before initiating steroids—look for dendritic lesions, unilateral presentation, and history of cold sores 1

2. Prolonged steroid use without tapering: This increases risk of IOP elevation, cataract formation, and potential viral reactivation 1, 3

3. Inadequate IOP monitoring: Steroid-induced glaucoma can develop insidiously; regular IOP checks are non-negotiable 1

4. Treating mild viral conjunctivitis with steroids: Most viral conjunctivitis is self-limited and requires only supportive care (artificial tears, cold compresses) 1, 4

5. Missing membranous conjunctivitis: Consider membrane debridement to prevent corneal abrasions and permanent cicatricial changes 1

Evidence Quality Note

The 2024 Ophthalmology Preferred Practice Pattern guidelines 1 provide the strongest evidence base for these recommendations. While some research suggests short-term steroid use may reduce symptom duration 5, 6, the guidelines appropriately emphasize restricting use to severe cases given the risk-benefit profile. The systematic review 7 confirms consistency across high-quality guidelines in recommending observation for most viral conjunctivitis cases.